N-Myc downstream-regulated gene 2 is involved in p53-mediated apoptosis

Nucleic Acids Research

Volumn 36, Issue 16, 2008, Pages 5335-5349

  Liu, Na ^a   Wang, Lifeng ^a   Li, Xia ^a   Yang, Qi ^a   Liu, Xinping ^a   Zhang, Jing ^a   Zhang, Jian ^a   Wu, Yousheng ^a   Ji, Shaoping ^a   Zhang, Yingqi ^a   Yang, Angang ^a   Han, Hua ^a   Yao, Libo ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MESSENGER RNA; N MYC DOWNSTREAM REGULATED PROTEIN 2; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL STRAIN HEK293; CONTROLLED STUDY; GENE CONTROL; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; INTRON; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN TARGETING; TRANSACTIVATION; TRANSCRIPTION REGULATION; TUMOR CELL; UPREGULATION; WILD TYPE;

APOPTOSIS; BINDING SITES; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; DNA DAMAGE; HUMANS; INTRONS; NEOPLASMS; RNA INTERFERENCE; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 52649132423     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkn504     Document Type: Article

References (60)

1. Vousden,K.H. and Lu,X. (2002) Live or let die: The cell's response to p53. Nat. Rev. Cancer, 2, 594-604.
2. Vogelstein,B., Lane,D. and Levine,A.J. (2000) Surfing the p53 network. Nature, 408, 307-310.
3. Fridman,J.S. and Lowe,S.W. (2003) Control of apoptosis by p53. Oncogene, 22, 9030-9040.
4. Yu,J. and Zhang,L. (2005) The transcriptional targets of p53 in apoptosis control. Biochem. Biophys. Res. Common., 331, 851-858.
5. Schmitt,C.A., Fridman,J.S., Yang,M., Baranov,E., Hoffman,R.M. and Lowe,S.W. (2002) Dissecting p53 tumor suppressor functions in vivo. Cancer Cell, 1, 289-298.
6. Hoffman,W.H., Biade,S., Zilfou,J.T., Chen,J. and Murphy,M. (2002) Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J. Biol. Chem., 277, 3247-3257.
7. Kho,P.S., Wang,Z., Zhuang,L., Li,Y., Chew,J.L., Ng,H.H., Liu,E.T. and Yu,Q. (2004) p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis. J. Biol. Chem., 279, 21183-21192.
8. Koumenis,C., Alarcon,R., Hammond,E., Sutphin,P., Hoffman,W., Murphy,M., Derr,J., Taya,Y., Lowe,S.W., Kastan,M. et al. (2001) Regulation of p53 by hypoxia: Dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol. Cell Biol., 21, 1297-1310.
9. Kokontis,J.M., Wagner,A.J., O'Leary,M., Liao,S. and Hay,N. (2001) A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function. Oncogene, 20, 659-668.
10. Yee,K.S. and Vousden,K.H. (2005) Complicating the complexity of p53. Carcinogenesis, 26, 1317-1322.
11. Bond,G.L., Hu,W. and Levine,A.J. (2005) MDM2 is a central node in the p53 pathway: 12 years and counting. Curr. Cancer Drug Targets, 5, 3-8.
12. Resnick-Silverman,L. and Manftedi,J.J. (2006) Gene-specific mechanisms of p53 transcriptional control and prospects for cancer therapy. J. Cell Biochem., 99, 679-689.
13. Giaccia,A.J. and Kastan,M.B. (1998) The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev., 12, 2973-2983.
14. el Deiry,W.S., Kern,S.E., Pietenpol,J.A., Kinzler,K.W. and Vogelstein,B. (1992) Definition of a consensus binding site for p53. Nat. Genet. 1, 45-49.
15. Lin,Y., Ma,W. and Benchimol,S. (2000) Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis. Nat. Genet., 26, 122-127.
16. Nakano,K. and Vousden,K.H. (2001) PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell, 7, 683-694.
17. Miyashita,T. and Reed,J.C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-299.
18. Muller,M., Wilder,S., Bannasch,D., Israeli,D., Lehlbach,K., Li-Weber,M., Friedman,S.L., Galle,P.R., Stremmel,W., Oren,M. et al. (1998) p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J. Exp. Med., 188, 2033-2045.
19. Sax,J.K., Fei,P., Murphy,M.E., Bernhard,E., Korsmeyer,S.J. and El Deiry,W.S. (2002) BID regulation by p53 contributes to chemosensitivity. Nat. Cell Biol., 4, 842-849.
20. Oda,E., Ohki,R., Murasawa,H., Nemoto,J., Shibue,T., Yamashita,T., Tokino,T., Taniguchi,T. and Tanaka,N. (2000) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science, 288, 1053-1058.
21. Wu,G.S., Burns,T.F., McDonald,E.R. III, Jiang,W., Meng,R., Krantz,I.D., Kao,G., Gan,D.D., Zhou,J.Y., Muschel,R. et al. (1997) KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat. Genet., 17, 141-143.
22. Bourdon,J.C., Renzing,J., Robertson,P.L., Fernandes,K.N. and Lane,D.P. (2002) Scotin, a novel p53-inducible proapoptotic protein located in the ER and the nuclear membrane. J. Cell Biol., 158, 235-246.
23. Adachi,K., Toyota,M., Sasaki,Y., Yamashita,T., Ishida,S., Ohe-Toyota,M., Maruyama,R., Hinoda,Y., Saito,T., Imai,K. et al. (2004) Identification of SCN3B as a novel p53-inducible proapoptotic gene. Oncogene, 23, 7791-7798.
24. Stein,S., Thomas,E.K., Herzog,B., Westfall,M.D., Rocheleau,J.V., Jackson,R.S., Wang,M. and Liang,P. (2004) NDRG1 is necessary for p53-dependent apoptosis. J. Biol. Chem., 279, 48930-48940.
25. Chipuk,J.E. and Green,D.R. (2006) Dissecting p53-dependent apoptosis. Cell Death Differ., 13, 994-1002.
26. Deng,Y.C., Yao,L.B., Liu,X.P., Nie,X.Y., Wang,J.C., Zhang,X.G. and Su,C.Z. (2001) Exploring a new gene containing ACP like domain in human brain and expression it in E. coli. Shengwu Huaxue Yu Shengwu Wuli Jinzhan (Prog. Biochem. Biophys.), 28, 72-76.
27. Zhou,R.H., Kokame,K., Tsukamoto,Y., Yutani,C., Kato,H. and Miyata,T. (2001) Characterization of the human NDRG gene family: A newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics, 73, 86-97.
28. Qu,X., Zhai,Y., Wei,H., Zhang,C., Xing,G., Yu,Y. and He,F. (2002) Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol. Cell Biochem., 229, 35-44.
29. Okuda,T. and Kondoh,H. (1999) Identification of new genes ndr2 and ndr3 which are related to Ndr1/RTP/Drg1 but show distinct tissue specificity and response to N-myc. Biochem. Biophys. Res. Common., 266, 208-215.
30. Zhang,J., Li,F., Liu,X., Shen,L., Liu,J., Su,J., Zhang,W., Deng,Y., Wang,L., Liu,N. et al. (2006) The repression of human differentiation-related gene NDRG2 expression by Myc via Miz-1-dependent interaction with the NDRG2 core promoter. J. Biol. Chem., 281 39159-39168.
31. Shimono,A., Okuda,T. and Kondoh,H. (1999) N-myc-dependent repression of ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant. Mech. Dev., 83, 39-52.
32. Zhou,D., Salnikow,K. and Costa,M. (1998) Cap43, a novel gene specifically induced by Ni2 + compounds. Cancer Res., 58, 2182-2189.
33. Chen,B., Nelson,D.M. and Sadovsky,Y. (2006) N-myc down-regulated gene 1 modulates the response of term human trophoblasts to hypoxic injury. J. Biol. Chem., 281, 2764-2772.
34. Wang,L., Liu,N., Yao,L., Li,F., Zhang,J., Deng,Y., Liu,J., Ji,S., Yang,A., Han,H. et al. (2008) NDRG2 is a new HIF-1 target gene necessary for hypoxia-induced apoptosis in A549 cells. Cell Physiol. Biochem., 21, 239-250.
35. Takahashi,K., Yamada,M., Ohata,H., Honda,K. and Yamada,M. (2005) Ndrg2 promotes neurite outgrowth of NGF-differentiated PC12 cells. Neurosci. Lett., 388, 157-162.
36. Angst,E., Sibold,S., Tiffon,C., Weimann,R., Gloor,B., Candinas,D. and Stroka,D. (2006) Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer. Br. J. Cancer, 95, 307-313.
37. Ellen,T., Ke,Q., Zhang,P. and Costa,M. (2008) NDRG1, a growth and cancer related gene: Regulation of gene expression and function in normal and disease states. Carcinogenesis, 29, 2-8.
38. Choi,S.C., Kim,K.D., Kim,J.T., Kim,J.W., Yoon,D.Y., Choe,Y.K., Chang,Y.S., Paik,S.G. and Lim,J.S. (2003) Expression and regulation of NDRG2 (N-myc downstream regulated gene 2) during the differentiation of dendritic cells. FEBS Lett., 553, 413-418.
39. Mitchelmore,C., Buchmann-Moller,S., Rask,L., West,M.J., Troncoso,J.C. and Jensen,N.A. (2004) NDRG2: A novel Alzheimer's disease associated protein. Neurobiol. Dis., 16, 48-58.
40. Kalaydjieva,L., Gresham,D., Gooding,R., Heather,L., Baas,F., de Jonge,R., Blechschmidt,K., Angelicheva,D., Chandler,D., Worsley,P. et al. (2000) N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. Am. J. Hum. Genet., 67, 47-58.
41. Bandyopadhyay,S., Pai,S.K., Hirota,S., Hosobe,S., Takano,Y., Saito,K., Piquemal,D., Commes,T., Watabe,M., Gross,S.C. et al. (2004) Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene, 23, 5675-5681.
42. Bandyopadhyay,S., Pai,S.K., Gross,S.C., Hirota,S., Hosobe,S., Miura,K., Saito,K., Commes,T., Hayashi,S., Watabe,M. et al. (2003) The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res., 63, 1731-1736.
43. Deng,Y., Yao,L., Chau,L., Ng,S.S., Peng,Y., Liu,X., Au,W.S., Wang,J., Li,F., Ji,S. et al. (2003) N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation. Int. J. Cancer, 106, 342-347.
44. Hu,X.L., Liu,X.P., Lin,S.X., Deng,Y.C., Liu,N., Li,X. and Yao,L.B. (2004) NDRG2 expression and mutation in human liver and pancreatic cancers. World J. Gastroenterol., 10, 3518-3521.
45. Lusis,E.A., Watson,M.A., Chicoine,M.R., Lyman,M., Roerig,P., Reifenberger,G., Gutmann,D.H. and Perry,A. (2005) Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Res., 65, 7121-7126.
46. Lorentzen,A., Vogel,L.K., Lewinsky,R.H., Saebo,M., Skjelbred,C.F., Godiksen,S., Hoff,G., Tveit,K.M., Lothe,I.M., Ikdahl,T. et al. (2007) Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma. BMC Cancer, 7, 192.
47. Choi,S.C., Yoon,S.R., Park,Y.P., Song,E.Y., Kim,J.W., Kim,W.H., Yang,Y., Lim,J.S. and Lee,H.G. (2007) Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death. Exp. Mol. Med., 39, 705-714.
48. Phillips,H.S., Kharbanda,S., Chen,R., Forrest,W.F., Soriano,R.H., Wu,T.D., Misra,A., Nigroj.M., Colman,H, Soroceanu,L. et al. (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell, 9, 157-173.
49. Nelson,W.G. and Kastan,M.B. (1994) DNA strand breaks: The DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell Biol., 14, 1815-1823.
50. El Deiry,W.S. (2001) Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling. Cell Death Differ., 8, 1066-1075.
51. Benchimol,S. (2001) p53-dependent pathways of apoptosis. Cell Death Differ., 8, 1049-1051.
52. Levine,A.J., Hu,W. and Feng,Z. (2006) The P53 pathway: What questions remain to be explored? Cell Death Differ., 13, 1027-1036.
53. MacLachlan,T.K. and El Deiry,W.S. (2002) Apoptotic threshold is lowered by p53 transactivation of caspase-6. Proc. Natl Acad. Sci. USA, 99, 9492-9497.
54. Moroni,M.C., Hickman,E.S., Lazzerini,D.E., Caprara,G., Colli,E., Cecconi,F., Muller,H. and Helin,K. (2001) Apaf-1 is a transcriptional target for E2F and p53. Nat. Cell Biol., 3, 552-558.
55. Fang,L., Li,G., Liu,G., Lee,S.W. and Aaronson,S.A. (2001) p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades. EMBO J., 20, 1931-1939.
56. Liu,X., Yue,P., Khuri,F.R. and Sun,S.Y. (2005) Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity. Cancer Res., 65, 9169-9175.
57. Ruiz,d.A., Ruiz-Ruiz,C., Rodriguez,A., Ortiz-Ferron,G., Redondo,J.M. and Lopez-Rivas,A. (2004) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) decoy receptor TRAIL-R3 is up-regulated by p53 in breast tumor cells through a mechanism involving an intronic p53-binding site. J. Biol. Chem., 279, 4093-4101.
58. Resnick,M.A., Tomso,D., Inga,A., Menendez,D. and Bell,D. (2005) Functional diversity in the gene network controlled by the master regulator p53 in humans. Cell Cycle, 4, 1026-1029.
59. Zhang,J., Liu,J., Li,X., Li,F., Wang,L., Zhang,J., Liu,X., Shen,L., Liu,N., Deng,Y. et al. (2007) The physical and functional interaction of NDRG2 with MSP58 in cells. Biochem. Biophys. Res. Commun., 352, 6-11.
60. Graeber,T.G., Peterson,J.F., Tsai,M., Monica,K., Fornace, A.J.Jr. and Giaccia,A.J. (1994) Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell Biol., 14, 6264-6277.